Back to dashboard
CommercialCoverageMedium impact

08.01.67c, Lurbinectedin (Zepzelca®)

Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
May 28, 2025
We identified it
Jun 19, 2026
Days to comply
—

Summary

This is a reissue of policy 08.01.67c regarding Lurbinectedin (Zepzelca®), a pharmacy policy for commercial plans. The policy will be reissued effective May 28, 2025, though specific content changes are not detailed in the summary.

Action Required

Action needed
By May 28, 2025: Billing team should review the full policy details at the provided URL to understand specific changes to Lurbinectedin (Zepzelca®) coverage requirements. Update billing procedures and prior authorization workflows as needed based on the complete policy content.

Related policy hubs